While a key consideration many patients have when assessing their treatment options is how effective the treatment has proven to be, patients also consider how a treatment will affect their lifestyle.
For patients considering stereotactic radiosurgery (SRS) or stereotactic body radiation therapy (SBRT) with CyberKnife®, the treatment has minimal impact on a patient’s daily routine and activities. Treatment is completed in five or fewer outpatient treatment sessions, each lasting about 30-90 minutes.
Many patients who work or travel may seek treatment options like CyberKnife due to the convenience of the treatment process without compromise of clinical quality. Clinical research has shown the treatment provides excellent outcomes and good local control rates for several types of cancers, including lung cancer, prostate cancer, brain tumors and metastatic cancer. View our Clinical Trials and Research page to learn more.
For more information about SRS and SBRT treatment, check out these testimonials from former CyberKnife patients.
This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.